Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Laila Khazai Image

      Laila Khazai, MD

      Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div

      About Dr. Laila Khazai

      I joined the faculty at MD Anderson Cancer Center in 8/2019, as a Breast Pathologist/Cytopathologist (my time allocated to 50% on each service). I truly enjoy clinical work and interaction with trainees. In my previous position, I was involved in several clinical trials (both within the institution and in multi-center trials). My goal is to spend the bulk of my time on patient care and education, meanwhile gradually get involved in clinical-oriented research projects, mainly supporting the pathology component of studies, as needed.


      Read More

      Present Title & Affiliation

      Primary Appointment

      Professor, Pathology, Anatomical, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Dual/Joint/Adjunct Appointment

      Associate Professor, Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2000Mashhad University of Medical Sciences, Mashhad, IR, Medicine, MD

      Postgraduate Training

      2011-2012Clinical Fellowship, Breast Pathology, University of Texas, Houston, Texas
      2009-2010Clinical Fellowship, Cytopathology, University of Texas, Houston, Texas
      2008-2009Clinical Fellowship, Surgical Pathology, University of Texas, Houston, Texas
      2004-2008Clinical Residency, Anatomic and Clinical Pathology, Vanderbilt University Medical School, Nashville, Tennessee
      2003-2004Clinical Residency, Preliminary surgery, Mayo Clinic, Rochester, Minnesota

      Licenses & Certifications

      2015California Medical license,
      2012Florida Medical License,
      2010American Board of Pathology, Cytopathology, Lifetime
      2009American Board of Pathology, Anatomic and Clinical Pathology, Lifetime
      2008Texas Medical License,

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Pathology, Moffitt Cancer Center, Tampa, FL, 2017 - 2019

      Assistant Professor, Pathology, Moffitt Cancer Center, Tampa, FL, 2012 - 2017

      Administrative Appointments/Responsibilities

      Quality Officer, Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present

      Selected Presentations & Talks

      Regional Presentations

      1. 2018. Breast Course. Conference. Florida Society of Clinical Oncology (FLASCO). Orlando, FL, US.
      2. 2018. Breast Pathology Course. Conference. Moffitt Cancer center. Tampa, FL, US.
      3. 2017. Head and Neck Pathology course. Conference. Moffitt Cancer center. Tampa, FL, US.
      4. 2017. Breast Course. Conference. Moffitt Cancer center. Sarasota, FL, US.
      5. 2015. Breast Course. Conference. Moffitt Cancer Center. Clearwater, FL, US.
      6. 2014. Breast course. Conference. RadList. Tampa, FL, US.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Ye, Q, Law, T, Klippel, D, Albarracin, C, Chen, H, Contreras, A, Ding, Q, Huo, L, Khazai, L, Middleton, LP, Resetkova, E, Sahin, AA, Sun, H, Sweeney, K, Symmans, WF, Wu, Y, Yoon, EC, Krishnamurthy, S. Prospective and Retrospective Analysis of Whole-Slide Images of Sentinel and Targeted Lymph Node Frozen Sections in Breast Cancer. Modern Pathology 38(4), 2025. e-Pub 2025. PMID: 39788205.
      2. Thomas, K, Trinh, H, Fei, A, Khazai, L, Sun, H, Gan, Q. Cytologic features of angiosarcoma in fluid specimens. Cancer Cytopathology 133(3), 2025. e-Pub 2025. PMID: 39992713.
      3. Wang, J, Chen, H, Koenig, J, Wu, Y, Bedrosian, I, Arun, BK, Ding, Q, Khazai, L, Resetkova, E, Huo, L, Sneige, N, Albarracin, C. Discordance of Oncotype DX scores in synchronous bilateral and unilateral multifocal breast cancers. Breast Cancer Research and Treatment 203(1):73-83, 2024. e-Pub 2024. PMID: 37751078.
      4. Adrada BE, Moseley TW, Kapoor, MM, Scoggins ME, Patel MM, Perez F, Nia ES, Khazai L, Arribas, E, Rauch GM, Guirguis MS. Triple-Negative Breast Cancer: Histopathologic Features, Genomics, and Treatment. RadioGraphics 43(10):1-15, 2023. e-Pub 2023. PMID: 37792593.
      5. Sahoo, S, Krings, G, Chen, YY, Carter, J, Chen, B, Guo, H, Hibshoosh, H, Reisenbichler, E, Fan, F, Wei, S, Khazai, L, Balassanian, R, Klein, M, Shad, S, Venters, S, Borowsky, AD, Symmans, WF, Tolgay Ocal, I. Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy. Archives of Pathology and Laboratory Medicine 147(5):591-603, 2023. e-Pub 2023. PMID: 35976643.
      6. Chen H, Ding Q, Khazai L, Zhao L, Damodaran S, Litton JK, Rauch GM, Yam C, Chang JT, Seth S, Lim B, Thompson AM, Mittendorf EA, Adrada B, Virani K, White JB, Ravenberg E, Song X, Candelaria R, Arun B, Ueno NT, Santiago L, Saleem S, Abouharb S, Murthy RK, Ibrahim N, Routbort MJ, Sahin A, Valero V, Symmans WF, Tripathy D, Wang WL, Moulder S, Huo L. PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens. Ther Adv Med Oncol 15:17588359231189422, 2023. e-Pub 2023. PMID: 37547448.
      7. Osdoit, M, Yau, C, Symmans, WF, Boughey, JC, Ewing, CA, Balassanian, R, Chen, YY, Krings, G, Wallace, A, Zare, S, Fadare, O, Lancaster, RB, Wei, S, Godellas, CV, Tang, P, Tuttle, TM, Klein, M, Sahoo, S, Hieken, TJ, Carter, J, Chen, B, Ahrendt, GM, Tchou, J, Feldman, MM, Tousimis, EA, Zeck, JC, Jaskowiak, NT, Sattar, H, Naik, AM, Lee, MC, Rosa, M, Khazai, L, Rendi, M, Lang, J, Lu, J, Tawfik, OW, Asare, S, Esserman, L, Mukhtar, RA. Association of Residual Ductal Carcinoma in Situ with Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial. JAMA Surgery 157(11):1034-1041, 2022. e-Pub 2022. PMID: 36069821.
      8. Yau C, Osdoit M, van der Noordaa M, Shad S, Wei J, de Croze D, Hamy AS, Laé M, Reyal F, Sonke GS, Steenbruggen TG, van Seijen M, Wesseling J, Martín M, Del Monte-Millán M, López-Tarruella S, Consortium IT, Boughey JC, Goetz MP, Hoskin T, Gould R, Valero V, Edge SB, Abraham JE, Bartlett JMS, Caldas C, Dunn J, Earl H, Hayward L, Hiller L, Provenzano E, Sammut SJ, Thomas JS, Cameron D, Graham A, Hall P, Mackintosh L, Fan F, Godwin AK, Schwensen K, Sharma P, DeMichele AM, Cole K, Pusztai L, Kim MO, van 't Veer LJ, Esserman LJ, Symmans WF. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. Lancet Oncol 23(1):149-160, 2022. e-Pub 2022. PMID: 34902335.
      9. Sura G, Lb|| K. Gastric Glomus Tumor on Fine Needle Aspiration. Diagn Cytyopath. e-Pub 2022.
      10. Symmans WF, Yau C, Chen YY, Balassanian R, Klein ME, Pusztai L, Nanda R, Parker BA, Datnow B, Krings G, Wei S, Feldman MD, Duan X, Chen B, Sattar H, Khazai L, Zeck JC, Sams S, Mhawech-Fauceglia P, Rendi M, Sahoo S, Ocal IT, Fan F, LeBeau LG, Vinh T, Troxell ML, Chien AJ, Wallace AM, Forero-Torres A, Ellis E, Albain KS, Murthy RK, Boughey JC, Liu MC, Haley BB, Elias AD, Clark AS, Kemmer K, Isaacs C, Lang JE, Han HS, Edmiston K, Viscusi RK, Northfelt DW, Khan QJ, Leyland-Jones B, Venters SJ, Shad S, Matthews JB, Asare SM, Buxton M, Asare AL, Rugo HS, Schwab RB, Helsten T, Hylton NM, van 't Veer L, Perlmutter J, DeMichele AM, Yee D, Berry DA, Esserman LJ. Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial. JAMA Oncol. e-Pub 2021. PMID: 34529000.
      11. Roy M, Teshome M, Damodaran S, Sahin AA, Khazai L, Arribas E, Candelaria RP, Scoggins ME, Lane DL, Giordano SH, Albarracin CT, Prieto VG, Nagarajan P. Male Mammary Paget Disease: A Tale of 2 Contrasting Cases. Am J Dermatopathol 42(12):981-985, 2020. e-Pub 2020. PMID: 33289978.
      12. Assi J, Khazai L. Synovial/Ganglion Cyst Involving the Sternoclavicular Joint. J Cytol 37(3):151-152, 2020. e-Pub 2020. PMID: 33088036.
      13. Khalil MF, Taggart MW, Khazai L. Lamellated mucin concretions mimicking adenocarcinoma. Diagn Cytopathol 48(7):690-691, 2020. e-Pub 2020. PMID: 32294299.
      14. Strang LR, Sun J, Sun W, Boulware D, Kiluk JV, Lee MC, Khazai L, Laronga C. Characteristics of Microinvasive Ductal Carcinoma In Situ Versus Noninvasive and Invasive Breast Cancer. J Surg Res 254:378-383. e-Pub 2020. PMID: 32535256.
      15. Roy M, Huang ML, Khazai L. Breast amyloid presenting as calcifications. Breast J. e-Pub 2020. PMID: 32452093.
      16. Lam CA, McGettigan MJ, Thompson ZJ, Khazal L, Chung CH, Centeno BA, McIver B, Valderrabano P. Ultrasound characterization for thyroid nodules with indeterminate cytology: inter-observer agreement and impact of combining pattern-based and scoring-based classifications in risk stratification. Endocrine 66(2):278-287. e-Pub 2019. PMID: 31300961.
      17. Nguyen L, Khazai L, Hakam A, Centeno BA, Rosa M. Diagnostic value of intraoperative rapid cytokeratin immunostain in the cytological evaluation of sentinel lymph nodes in patients with invasive lobular carcinoma. Diagn Cytopathol 47(5):482-487, 2019. e-Pub 2019. PMID: 30589516.
      18. Agosto-Arroyo E, Tahmasbi M, Al Diffalha S, Khazai L, Xiong Y, Rosa M. Invasive Breast Carcinoma Tumor Size on Core Needle Biopsy: Analysis of Practice Patterns and Effect on Final Pathologic Tumor Stage. Clin Breast Cancer 18(5):e1027-e1030, 2018. e-Pub 2018. PMID: 29622383.
      19. Khazai L, Agosto-Arroyo E, Rosa M. P40 Immunostain Does Not Outperform p63 as a Myoepithelial Cell Marker in the Daily Practice of Breast Pathology. Appl Immunohistochem Mol Morphol 26(8):599-604, 2018. e-Pub 2018. PMID: 28549030.
      20. Valderrabano P, Khazai L, Thompson ZJ, Otto KJ, Hallanger-Johnson JE, Chung CH, Centeno BA, McIver B. Association of Tumor Size With Histologic and Clinical Outcomes Among Patients With Cytologically Indeterminate Thyroid Nodules. JAMA Otolaryngol Head Neck Surg 144(9):788-795, 2018. e-Pub 2018. PMID: 30027226.
      21. Valderrabano P, Khazai L, Thompson ZJ, Leon ME, Otto KJ, Hallanger-Johnson JE, Wadsworth JT, Chung CH, Centeno BA, McIver B. Impact of oncogene panel results on surgical management of cytologically indeterminate thyroid nodules. Head Neck 40(8):1812-1823, 2018. e-Pub 2018. PMID: 29624786.
      22. Valderrabano P, McGettigan MJ, Lam CA, Khazai L, Thompson ZJ, Chung CH, Centeno BA, McIver B. Thyroid Nodules with Indeterminate Cytology: Utility of the American Thyroid Association Sonographic Patterns for Cancer Risk Stratification. Thyroid 28(8):1004-1012, 2018. e-Pub 2018. PMID: 29848195.
      23. Marshall C, Mounzer R, Hall M, Simon V, Centeno B, Dennis K, Dhillon J, Fan F, Khazai L, Klapman J, Komanduri S, Lin X, Lu D, Mehrotra S, Muthusamy VR, Nayar R, Paintal A, Rao J, Sams S, Shah J, Watson R, Rastogi A, Wani S. Suboptimal Agreement Among Cytopathologists in Diagnosis of Malignancy Based on Endoscopic Ultrasound Needle Aspirates of Solid Pancreatic Lesions: A Validation Study. Clin Gastroenterol Hepatol 16(7):1114-1122.e2, 2018. e-Pub 2018. PMID: 28911946.
      24. Rosa M, Khazai L. Comparison of HER2 testing among laboratories: Our experience with review cases retested at Moffitt Cancer Center in a two-year period. Breast J 24(2):139-147, 2018. e-Pub 2018. PMID: 28703376.
      25. Valderrabano P, Khazai L, Leon ME, Thompson ZJ, Ma Z, Chung CH, Hallanger-Johnson JE, Otto KJ, Rogers KD, Centeno BA, McIver B. Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology. Endocr Relat Cancer 24(3):127-136, 2017. e-Pub 2017. PMID: 28104680.
      26. Agosto-Arroyo E, Rosa M, Chau A, Khazai L. Concurrent BRAF and PTEN mutations in melanoma of unknown origin presenting as a breast mass. SAGE Open Med Case Rep 5:2050313X17711064, 2017. e-Pub 2017. PMID: 28607685.
      27. Al Diffalha S, Agosto-Arroyo E, Rosa M, Khazai L. Symmetrical lipomatosis of tongue, misdiagnosed as primary amyloidosis. Human Path Case Reports, 2017. e-Pub 2017.
      28. Valderrabano P, Montilla-Soler J, Mifsud M, Leon M, Centeno B, Khazai L, Padhya T, McCaffrey T, Russell J, McIver B, Otto K. Hypermetabolism on (18)F-Fluorodeoxyglucose Positron Emission Tomography Scan Does Not Influence the Interpretation of Thyroid Cytopathology, and Nodules with a SUVmax <2.5 Are Not at Increased Risk for Malignancy. Thyroid 26(9):1300-7, 2016. e-Pub 2016. PMID: 27324615.
      29. Khazai L, Falcon S, Rosa M. Metastatic Salivary Duct Carcinoma to the Breast. Breast J 22(4):461-3, 2016. e-Pub 2016. PMID: 27089239.
      30. Khazai L, Chau A, Hoover S, Rosa M. Papillary endothelial hyperplasia arising in the irradiated breast: A diagnostic dilemma. Pathol Res Pract 212(7):604-7, 2016. e-Pub 2016. PMID: 27157404.
      31. Valderrabano P, Leon ME, Centeno BA, Otto KJ, Khazai L, McCaffrey JC, Russell JS, McIver B. Institutional prevalence of malignancy of indeterminate thyroid cytology is necessary but insufficient to accurately interpret molecular marker tests. Eur J Endocrinol 174(5):621-9, 2016. e-Pub 2016. PMID: 26903551.
      32. Patel BK, Jafarian N, Abbott AM, Khazai L, Lee MC. Imaging Findings and Management of Primary Breast Cancer in Accessory Axillary Breast Tissue. Clin Breast Cancer 15(4):e223-9, 2015. e-Pub 2015. PMID: 25986957.
      33. Khazai L, Middleton LP, Goktepe N, Liu BT, Sahin AA. Breast pathology second review identifies clinically significant discrepancies in over 10% of patients. J Surg Oncol 111(2):192-7, 2015. e-Pub 2015. PMID: 25273328.
      34. Khazai L, Kundu UR, Jacob B, Patel S, Sneige N, Eapen GA, Morice RC, Caraway NP. Endobronchial ultrasound-guided transbronchial needle aspiration biopsy is useful evaluating mediastinal lymphadenopathy in a cancer center. Cytojournal 8:10, 2011. e-Pub 2011. PMID: 21712956.
      35. Resetkova E, Khazai L, Albarracin CT, Arribas E. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast. Breast J 16(6):573-80, 2010. e-Pub 2010. PMID: 21070433.
      36. Dimashkieh HH, Khazai L, Novak GD, Casey MB. Pathologic quiz case: an 83-year-old woman with a uterine cervical mass. Adenoid cystic carcinoma. Arch Pathol Lab Med 128(7):817-8, 2004. e-Pub 2004. PMID: 15214839.
      37. Khazai L. Chronic diarrhea and weight loss in an elderly patient. Contemporary Surgery, 2004. e-Pub 2004.
      38. Khazai L, Grinberg G. Hepatocelluar carcinoma and fatigue in an otherwise healthy 89-year-old man. Contemporary Surgery, 2004. e-Pub 2004.

      Review Articles

      1. Patel, MM, Adrada, BE, Nia, ES, Kapoor, MM, Khazai, L, Guirguis, MS, Perez, F, Moseley, T, Arribas, E. Multimodality Imaging of Breast Cancer Recurrence Post Breast Conservation Therapy. Current Radiology Reports 12(2):9-18, 2024. e-Pub 2024.
      2. Valderrabano P, Khazai L, Thompson ZJ, Sharpe SC, Tarasova VD, Otto KJ, Hallanger-Johnson JE, Wadsworth JT, Wenig BM, Chung CH, Centeno BA, McIver B. Cancer Risk Associated with Nuclear Atypia in Cytologically Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis. Thyroid 28(2):210-219, 2018. e-Pub 2018. PMID: 29160163.
      3. Khazai L, Rosa M. Use of Immunohistochemical Stains in Epithelial Lesions of the Breast. Cancer Control 22(2):220-5, 2015. e-Pub 2015. PMID: 26068768.

      Other Articles

      1. Sura, GH, Khazai, L Gastric glomus tumor on fine needle aspiration. Diagnostic Cytopathology 50(12):581-582, 2022. PMID: 36101971.
      2. Rolon, MR, Khazai, L Classic cytomorphological features of Langerhans cell histiocytosis with osseous involvement. Diagnostic Cytopathology 50(12):579-580, 2022. PMID: 36047490.

      Abstracts

      1. Thomas K, Khazai L, Gan Q. Angiosarcoma in Fluids: A Review of Cytologic Features in 22 Patients. Mod Pathol 104(3):S480-S482, 2024. e-Pub 2024.
      2. Ye Q, Klippel D, Albarracin C, Chen H, Contreras A, Ding Q, Huo L, Khazai L, Middleton L, Resetkova E, Sahin A, Sun H, Sweeney K, Symmans W, Wu Y, Krishnamurthy S. A Prospective Study of Real Time Whole Slide Imaging of Frozen Sections for Intraoperative Evaluation of Axillary Sentinel Lymph Nodes in Breast Cancer. Mod Pathol 104(3):S321-S322, 2024. e-Pub 2024.
      3. Chen H, Wu Y, Ding Q, Huo L, Khazai L, Sahin A, Albarracin C. HER2-low Breast Cancers: Comparison of HER2 Scores by Immunohistochemistry and Oncotype DX. Mod Path 103(3):S114, 2023. e-Pub 2023.
      4. Gan Q, Kundu U, Chatterjee D, Krishnamurthy S, Taherian M, Ali H, Diks J, Rodriguez J, Shen Y, Khazai L, Donthi D, Gomez M, Gupta S, Wang H. Distinction of Grade 3 Pancreatic Neuroendocrine Tumor versus Carcinoma using Cytomorphologic Assessment of FNA Material: Is It Doable and Does Experience Matter?. Mod Path 103(3, Supplement):S299-300, 2023. e-Pub 2023.
      5. Adrada B, Moseley T, Rauch G, Patel M, Perez F, Kappoor M, Nia E, Scoggins M, Khazai L, Arribas E, Guirguis M. The Many Faces of Triple Negative Breast Cancer. RSNA Journals, 2022. e-Pub 2022.
      6. Patel M, Adrada B, Nia E, Kapoor M, Khazai L, Guirguis M, Perez F, Moseley T, Arribas E. Multimodality Imaging of Breast Cancer Recurrence. RSNA Journals, 2022. e-Pub 2022.
      7. Carter JM, Klein ME, Venters SJ, Rabe K, Ocal I, Singh K, Wolf DM, Sahoo S, Harada S, Khazai L, Harigopal M, Borowsky AD, Krings G, Balassanian R, Chen Y, Cole K, Shad S, Delson A, Brown-Swigart L, Consortium IT, Esserman L, ‘t Veer LV, Symmans W. Pathologic features of the inter-regimen biopsy predict response to neoadjuvant therapy in the I-SPY 2 TRIAL. 2020 San Antonio Breast Cancer Virtual Symposium 81(4):PS4-09, 2021. e-Pub 2021.
      8. Venters SJ, Li W, Wolf DM, Carter JM, Klein ME, Singh K, Rabe K, Ocal I, Newitt D, Yau C, Onishi N, Gibbs J, Sahoo S, Harada S, Khazai L, Harigopal M, Borowsky AD, Krings G, Balassanian R, Chen Y, Cole K, Shad S, LeStage B, Delson A, Finestone S, Brown-Swigart L, Working Group II, Consortium IT, Esserman L, ‘t Veer LV, Symmans W, Hylton NM. Serial MRI and pathology combined to select candidates for therapy de-escalation in the I-SPY 2 TRIAL. Cancer Res 81(4):PS4-10, 2021. e-Pub 2021.
      9. Onishi N, Li W, Venters SJ, Wolf DM, Newitt DC, Price ER, Gibbs J, LeStage B, Working Group TIP, Working Group TII, Consortium TI, Symmans WF, Hylton NM. Radiologic review to refine selection of candidates for de-escalation of neoadjuvant therapy. 2020 San Antonio Breast Cancer Virtual Symposium 81(4 Supplement):PS3-02, 2021. e-Pub 2021.
      10. Di Pasquale L, Khazai L, Xiong Y, Agosto-arroyo E. Impact of 2018 American Society of Clinical Oncology/College of American Pathologists Clinical Guidelines Update on HER-2 Oncogene Testing in Breast Cancer Cases. Proceedings from United States and Canadian Society of Pathologists (USCAP), 2019. e-Pub 2019.
      11. Di Pasquale L, De Jesus J, Xiong Y, L <, Agosto-arroyo, E, Rosa M. Analysis of Concordance Between Radiologic Imaging Modalities, Final Pathologic Tumor Size and Focality in Invasive Breast Carcinoma. Proceedings from United States and Canadian Society of Pathologists (USCAP), 2019. e-Pub 2019.
      12. Rosa M, Agosto-arroyo E, Hakam A, Centeno B, Mela N, Khazai L. Diagnostic value of Intraoperative Rapid Cytokeratin Immunostain in the Cytological Evaluation of Sentinel Lymph Nodes in Patients with Invasive Lobular Carcinoma. Proceeding from American Society of Cytopathology (ASC), 2017. e-Pub 2017.
      13. Mounzer R, Marshall C, Hall M, SImon V, Centeno B, Dennis K, Dhillon J, Fan F, Khazai L, Klapman J, Komanduri S, Lu D, Mehrota S, Muthusamy V, Nayar R, Paintal A, Rao J, Sams S, SHah J, Tynan T, Watson R, Rastogi A, Wani S. Predictors of interobserver variability (IOV) among cytopathologists evaluating ultrasound fine needle aspiration (EUS-FNA) cytology speaimens: Amulticenter validation study. Proceedings from Digestive Disease Week, 2017. e-Pub 2017.
      14. Wani S, Mounzer R, Hall M, Simon V, Centeno B, Dennis K, Dhillon J, fan F, Khazai L, Klapman J, Komanduri S, Lin X, Lu D, Mehrota S, Muthusamy V, Watson R, Rastogi A, Marshall C. Suboptimal interobserver agreement (IOA) AMong cytopathologists for pancreatic endoscopic ultrasound fine needle aspiration (EUS-FNA) cytology specimens. Proceedings from Digestive Disease Week, 2017. e-Pub 2017.
      15. Khazai L, Dhillon J. Utility and Reliability of Cell Block Sections in Predicting HPV status on metastatic HNSCC to Neck Nodes. Proceedings from United States and Canadian Society of Pathologists (USCAP), 2017. e-Pub 2017.
      16. Dominguez C, Xiong Y, Khazai L, Rosa M, Agosto-Arroyo E. Accurate assessment of tumor size in breast cancer patients: Comparison of different radiological modalities with final pathology. Proceedings from United States and Canadian Society of Pathologists (USCAP), 2017. e-Pub 2017.
      17. Valderrabano P, Khazai L, Leon M, Thompson Z, Ma Z, Otto K, Rogers K, Centeno B, McIver B. Impact of NIFTP reclassification on THYROSEQ V2 performance: A single center independent validation study. Proceedings from American Thyroid Association (ATA), 2016. e-Pub 2016.
      18. Agosto-Arroyo E, Xiong Y, L . Correlation of Intraoperative, Macroscopic and Final Pathologic Tumor Size Measurement in Breast Cancer Patients. Proceedings from College of American Pathologists (CAP), 2016. e-Pub 2016.
      19. Agosto-Arroyo E, Rosa M, Chau A, Khazai, L. The Great Mimicker: Metastatic melanoma presenting as breast mass without a cutaneous lesion. Proceedings from College of American Pathologists (CAP), 2016. e-Pub 2016.
      20. Agosto-Arroyo E, Rosa, M, Drukteinis, J, Khazai, L. Chondroid lesions of the breast on minimally invasive procedures- diagnostic challenges. Proceedings from College of American Pathologists (CAP), 2016. e-Pub 2016.
      21. Tahmasbi M, Al Diffalha S, Agosto-Arroyo E, Khazai L, Rosa M. Impact of core needle biopsy tumor size on final pathologic tumor staging in breast carcinomas. Proceedings from College of American Pathologists (CAP), 2016. e-Pub 2016.
      22. Valderrabano P, Otto K, McCaffrey J, Leon M, Khazai L, Centeno B, McIver B. The impact of molecular marker test results on surgical management of cytologically indeterminate thyroid nodules. Proceedings from International Thyroid Congress, 2015. e-Pub 2015.
      23. Abbott AM, Jafarian N, Patel B, Khazai L, Lee CM. Management of primary breast cancer in accessory breast tissue. Proceedings from Annual Miami Breast Cancer Conference, 2015. e-Pub 2015.
      24. Rosa M, Magliocco A Khazai L. Benefits of a second opinion in breast pathology. Proceedings from United States and Canadian Society of Pathologists (USCAP), 2014. e-Pub 2014.
      25. Shah S, Rosa M, Khazai L. Microglandular adenosis; a diagnostic pitfall. Proceedings from Florida Society of Pathologists (FSP), 2014. e-Pub 2014.
      26. Rosa M, Khazai L, Bui M. Intraoperative imprint cytology evaluation of sentinel lymph nodes in breast carcinoma. Proceedings from American Association of Cytopathology, 2013. e-Pub 2013.
      27. Khazai L, Middleton L, Sahin A. “Breast pathology review identifies clinically significant discrepancies in 10% of cases. Proceedings from United States and Canadian Society of Pathologists (USCAP), 2012. e-Pub 2012.
      28. Valderrabano P, Leon M, Khazai L, Centeno B, McIver B. Subclassification of indeterminate categories of thyroid cytopathology improves risk stratification and could be used to select and interpret the results of molecular marker tests. Proceedings from International Thyroid Congress, 2010. e-Pub 2010.
      29. Yoon E, Salem A, Chen H, Albarracin C, Wu Y, Sneige N, Khazai L, Ding Q, Tang Z, Sahin A. Correlation amongst Immunohistochemical (IHC) Scores, Fluorescence In Situ Hybridization (FISH) Groups and Final HER2 Status on Breast carcinoma (BC) and Quality Issues Surrounding Indeterminate FISH Tests: A Single Center Experience.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top